Supervised Asthma Medication in Schools (SAMS)



Status:Completed
Conditions:Asthma
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:5 - 12
Updated:12/14/2017
Start Date:August 2014
End Date:June 2016

Use our guide to learn which trials are right for you!

The Cost Effectiveness of School-Based Supervised Asthma Therapy

The investigators hypothesize that school-based, direct supervision of daily controller
therapy will result in more effective asthma control, as assessed by the Asthma Control
Questionnaire than usual care. Additionally, as the result of enhanced asthma control and
resulting decrease in health care utilization, school-based, direct supervision of daily
controller therapy will result in lower cost per quality-adjusted life year (QALY) gained
than usual care.

This research is being done to test if children with asthma will have fewer asthma symptoms
if they are monitored at school to make sure they take their inhaled steroid medication (ICS)
every day and take the medication the right way. All of the children with asthma in the
school will be asked to participate. In the first year in one-half of the schools, children
and school staff will participate in a standardized asthma education program presented by the
American Lung Association (ALA). Children will have daily monitoring of their inhaled asthma
medication. The other half of schools will continue with the usual treatment of children with
asthma. In the second year of the study, all schools and children will have the asthma
education program and monitoring. Parents will be queried quarterly for information about
their child's asthma.

Inclusion Criteria:

- A child with asthma attending a Tucson Unified School District elementary school
selected for the study.

Exclusion Criteria:

- No asthma.

- Not attending a Tucson Unified School District elementary school selected for the
study.
We found this trial at
1
site
?
mi
from
Tucson, AZ
Click here to add this to my saved trials